Insilicotrials
Founded 2018 · 30 employees on LinkedIn · 4 known investors
Find your way into Insilicotrials
InSilicoTrials provides a platform for clinical trial simulation and design optimization using mechanistic models, AI, and digital twins. The platform helps pharmaceutical companies, biotech firms, and regulators reduce development risk and accelerate the path from drug discovery to patient access.
Investors · 4
Competitors · 3
by search overlap
Insilico Medicine33 shared keywordsInsilico Medicine uses artificial intelligence to discover and develop new drugs, operating an AI-driven platform for pharmaceutical research and development. It collaborates with global biopharma companies and academic institutions on drug discovery projects.
Labcorp14 shared keywordsLabCorp provides diagnostic testing services and clinical trial recruitment solutions that connect patient insights to drug development for healthcare providers.
Patheon12 shared keywordsPatheon, part of Thermo Fisher Scientific, is a contract development and manufacturing organization (CDMO) that also offers clinical research (CRO) services for biotechnology and pharmaceutical sponsors. It supports drug development from early-stage R&D through clinical supply and commercial manufacturing across a global network of more than 60 sites.
Companies competing with Insilicotrials for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Insilicotrials do?
- InSilicoTrials provides a platform for clinical trial simulation and design optimization using mechanistic models, AI, and digital twins. The platform helps pharmaceutical companies, biotech firms, and regulators reduce development risk and accelerate the path from drug discovery to patient access.
- Who are Insilicotrials's investors?
- Insilicotrials's investors include Levante Capital, Moonstone Venture Capital, Pi Campus, United Ventures.